RECRUITING

The Feasibility of the Pray Until Something Happens (PUSH) Intervention-OUTPATIENT

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this research study is to reduce stress and improve sickle cell disease (SCD) pain control and sleep quality with less opioid use by determining the feasibility of an intervention with self-management combined intercessory and petitionary prayer, named Pray Until Something Happens (PUSH) stress reduction intervention using a mobile smart device. Currently, opioid analgesics are primarily used to treat SCD pain while self-managed behavioral modalities such as PUSH, are rarely used. Little is known about the effects or mechanisms of PUSH on pain, stress, and sleep symptoms in adults with SCD. Emerging evidence from the hypothalamic pituitary adrenal (HPA) axis theory offer insights for understanding the mechanisms. Adding PUSH as a supplement to analgesic therapies will address the dearth of self-management strategies for controlling pain in SCD. PUSH is a simple and cost-effective non-drug intervention that could reduce pain and stress in inpatients with SCD. GR is an intervention where inpatients with SCD are directed to listen to the audio recordings of the PUSH prayer session.

Official Title

A Pilot Study of Everyday Stress and Pain Intensity Reduction Intervention Via Tongues and Understanding Study in Adult Outpatients With Sickle Disease (ESPIRITU Study)

Quick Facts

Study Start:2025-01-21
Study Completion:2025-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06580067

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 99 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Has SCD diagnosis;
  2. * Reports pain 3 or greater in the previous 24 hours (0-10 scale)
  3. * Speaks and reads English
  4. * 18 years of age or older
  5. * Uses opioid analgesics on "as needed" or "continuous" basis
  6. * Allows healing prayers to be offered for them in the name of Jesus Christ
  1. * Legally blind
  2. * Physically or cognitively unable to complete study measures

Contacts and Locations

Study Contact

Miriam O Ezenwa, PhD, RN
CONTACT
352-273-6344
moezenwa@ufl.edu
Diana J Wilkie, PhD, RN,FAAN
CONTACT
352-273-6401
diwilkie@ufl.edu

Principal Investigator

Miriam O Ezenwa,, PhD, RN
PRINCIPAL_INVESTIGATOR
University of Florida

Study Locations (Sites)

University of Florida
Gainesville, Florida, 32610
United States

Collaborators and Investigators

Sponsor: University of Florida

  • Miriam O Ezenwa,, PhD, RN, PRINCIPAL_INVESTIGATOR, University of Florida

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-21
Study Completion Date2025-11

Study Record Updates

Study Start Date2025-01-21
Study Completion Date2025-11

Terms related to this study

Additional Relevant MeSH Terms

  • Sickle Cell Disease
  • Stress
  • Pain